Filing Details
TuHURA Biosciences, Inc./NV (NASDAQ:HURA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:HURA
TuHURA Biosciences, Inc./NV (HURA) Files Quarterly Report for Q0
TuHURA Biosciences, Inc./NV (NASDAQ:HURA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
TuHURA Biosciences, Inc./NV (NASDAQ:HURA) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- TuHURA Biosciences, Inc./NV (NASDAQ: HURA) filed its quarterly report (Form 10-Q) with the SEC on August 14, 2026.
- The company's stock trades at $2.47 with a market capitalization of $52.9 million.
- The 10-Q filing includes unaudited financial statements and management commentary on recent performance, though specific revenue figures were not disclosed in this summary.
Market Context
TuHURA Biosciences, Inc./NV's stock currently trades at $2.47 with a market capitalization of $52.9M.
The 10-Q provides TuHURA Biosciences, Inc./NV's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for TuHURA Biosciences, Inc./NV are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View HURA Stock Page
Frequently Asked Questions
Where can I read HURA's SEC filings?
Browse all filings on our HURA SEC filings page.
What types of SEC filings does TuHURA Biosciences, Inc./NV file?
Public companies like TuHURA Biosciences, Inc./NV file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.